Salivary Gland Cancers
5 clinical trials · Condition
◉ Watch Salivary Gland Cancers
| Record | Firm | Date |
|---|---|---|
| Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (NCT02568267) | Hoffmann-La Roche | 2015-11-19 |
| Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 (NCT02857712) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-12-01 |
| A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands (NCT01678105) | Ontario Clinical Oncology Group (OCOG) | 2012-11-01 |
Track Salivary Gland Cancers automatically
Every clearance here is in the API, with alerts when new ones post.